These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3552018)

  • 21. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
    Shim HS; Jung WH; Kim H; Park K; Cho NH
    APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical detection of prolactin binding sites in fine needle aspiration smears of breast lesions.
    Tandon S; Agarwal PK; Mishra KL; Goel A; Kumar S
    Indian J Med Res; 1993 Apr; 98():61-4. PubMed ID: 8344732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
    Tramm T; Kim JY; Leibl S; Moinfar F; Tavassoli FA
    Virchows Arch; 2016 Sep; 469(3):285-95. PubMed ID: 27287269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer.
    Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH
    Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relation of epithelial metaplasia and calcification with epithelial proliferation in fibrocytic breast disease].
    Savjak D; Pikula B
    Med Arh; 1991; 45(1-2):59-62. PubMed ID: 1366322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases.
    Hanna W; Kahn HJ; Andrulis I; Pawson T
    Mod Pathol; 1990 Jul; 3(4):455-61. PubMed ID: 1977159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease.
    Papamichalis G; Francia K; Karachaliou FE; Anastasiades OT; Spandidos DA
    Anticancer Res; 1988; 8(6):1217-22. PubMed ID: 3064712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.
    diFlorio-Alexander RM; Marotti JD; Bond JS; Schwab MC; Memoli VA; Wells WA; Poplack SP
    AJR Am J Roentgenol; 2015 Jan; 204(1):211-8. PubMed ID: 25539259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T; Kim JY; Tavassoli FA
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interaction between beta-endorphin, steroids and peptide hormones in fibrocystic lesions of the female breast].
    Schurz B
    Wien Klin Wochenschr Suppl; 1991; 187():3-26. PubMed ID: 1648846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
    Egan MJ; Newman J; Crocker J; Collard M
    Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody B72.3 in benign breast lesions.
    Soomro S; Shousha S
    J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is cystic disease related to breast cancer?
    Haagensen DE
    Am J Surg Pathol; 1991 Jul; 15(7):687-94. PubMed ID: 2058763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.
    Sitterding SM; Wiseman WR; Schiller CL; Luan C; Chen F; Moyano JV; Watkin WG; Wiley EL; Cryns VL; Diaz LK
    Ann Diagn Pathol; 2008 Feb; 12(1):33-40. PubMed ID: 18164413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies 323/A3 and Ca1 identify a paracrine function of breast carcinoma on adjacent benign histological components.
    Courtney SP; Williams S; Mansel RE
    Br J Cancer Suppl; 1990 Jul; 10():92-5. PubMed ID: 1696492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The microenvironment of human breast with clinical cancer.
    Sarnelli R; Squartini F
    Appl Pathol; 1983; 1(6):323-32. PubMed ID: 6679791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
    Selim AG; El-Ayat G; Wells CA
    Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid receptors in benign breast disease, gross cystic disease and fibroadenoma.
    Nardelli GB; Lamaina V; Siliotti F
    Clin Exp Obstet Gynecol; 1987; 14(1):10-5. PubMed ID: 3815831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.